Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

04/29/11 IBTA E News April 2011        

04/29/11 Neurosurgeons Shed Scrubs and Suit up in Softball Uniforms to Battle Pediatric Brain Tumors        

04/27/11 Valproic Acid and Warfarin: An Underrecognized Drug Interaction.        

04/27/11 Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy.        

04/27/11 Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.        

04/27/11 The natural history of extracranial metastasis from glioblastoma multiforme.        

04/27/11 Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials.        

04/27/11 Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion.        

04/27/11 Quick survey on location for brain tumor conference        

04/26/11 "Meeting the Unique Needs of Brain Tumor Caregivers " a free seminar in NJ for individuals and families coping with all types of brain tumors        

04/25/11 9-year-old marathon runner and family to raise brain tumor awareness        

04/25/11 NICO Corporation passes 1,000 case mark; receives CE Mark approval for use of minimally invasive brain surgery tool in European markets        

04/25/11 The Legacy Brain Foundation 2011 Celebration of Life        

04/15/11 May is Brain Tumor Awareness Month        

04/15/11 Identification of Protein Biomarkers Offers Promise for Children with Deadly Brainstem Gliomas (Funded by the Musella Foundation!)        

04/15/11 FDA clears first-of-a-kind device for brain cancer (Mentions Musella Foundation!)        

04/15/11 FDA Approves the NovoTTF-100A System for the Treatment of Patients with Recurrent Glioblastoma Multiforme (GBM) Brain Tumors        

04/08/11 Benefits of interferon-ß and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study.        

04/08/11 Bevacizumab (Avastin) for recurrent glioblastoma multiforme: a meta-ana lysis.        

---

Displaying Stories 2761 to 2780 of 7673
Previous 20           Next 20